Glucagon
Product Images NDC 64725-8031

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Glucagon (NDC 64725-8031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 8031)

The label for Glucagon Emergency Kit (1mg) shows it is prescription only. It includes placeholder text for lot number and expiration date. The original manufacturer is Lilly, and it is repackaged by TYA Pharmaceuticals at 2030 Crescent Dr., Tallahassee, FL 32301, with a contact phone number. A barcode is also present, and dosing instructions advise to see the package insert.*

FDA Label Image

Primary Sequence Of Glucagon (Glucagon F001 V01)

Chemical structure diagram of the peptide sequence for Glucagon showing amino acids in a linear chain from the amino (H2N) end.*

FDA Label Image

Figure 1a (Glucagon F002a V01)

A line graph depicting glucagon concentrations (ng/mL) over time from dosing (hours). It shows a rapid rise in glucagon concentration peaking between 0.5 and 1 hour, followed by a gradual decline back to baseline by 3 hours. Error bars indicate variability at each time point.*

FDA Label Image

Figure 1b (Glucagon F002b V01)

A line graph showing blood glucose concentrations in mg/dL over a 4-hour period. The x-axis represents time in hours, and the y-axis shows blood glucose levels. The graph depicts an initial rise in blood glucose concentration peaking before 1 hour, followed by a decline and stabilization for the remainder of the time.*

FDA Label Image

Step 1 Figure (Glucagon F003 V01)

Black-and-white line drawing illustrating a hand holding and pressing down the top of a small spray or pump device, with an arrow indicating the pressing motion direction.*

FDA Label Image

Step 2 Figure (Glucagon F004 V02)

Instructional line drawing showing two hands preparing a syringe with a vial. One hand holds the syringe with an arrow indicating the plunger is being pulled back, while the other hand stabilizes the vial, illustrating the process of drawing medication into the syringe.*

FDA Label Image

Step 3 Figure (Glucagon F005 V02)

Illustration showing a hand holding a small vial or container and rotating it in a circular motion, indicating mixing or swirling. The image suggests preparation or activation of the contents by gentle rotation.*

FDA Label Image

Step 4 Figure (Glucagon F006 V01)

An instructional illustration showing a hand holding a syringe inserted into the lower leg area, with a downward arrow indicating the direction for an injection administration technique, associated with Glucagon by TYA Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.